| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |